jnj

Johnson & Johnson's Q3 Earnings Drop but Beat Estimates

Johnson & Johnson's Q3 Earnings Drop but Beat Estimates

On Tuesday, Johnson & Johnson (NYSE: JNJ) announced its financial results for the third quarter of 2017. The company also adjusted its guidance for full-year 2017 in the statement on Tuesday.For the third quarter of 2017, the company announced s..

National Institute of Health partners with 11 Biopharma companies for Cancer Research

National Institute of Health partners with 11 Biopharma companies for Cancer Research

The National Institutes of Health and 11 biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT). This is a five-year-public-private research collaboration totaling $215 million as part of the Cancer Moons..

Johnson and Johnson stocks rise as 2017 forecasts are raised

Johnson and Johnson stocks rise as 2017 forecasts are raised

Johnson & Johnson (NYSE: JNJ), an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886, is expecting sales growth to pick up in the second half of the fiscal year 2017, as they ..